A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum. - Wikidata - wikimedia - TriplyDB

A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.

A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.

http://www.wikidata.org/entity/Q33916132

about

The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder.Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.Molecular Mechanisms Underlying Accelerated Aging by Defects in the FGF23-Klotho System.Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk

P2860

Q38693604-6CD9F284-4935-4B54-BB98-3EC117168E20 Q49299964-1CDF2392-856B-418C-B680-54F2860410C6 Q54961270-DF926D27-0E08-40AE-9E22-2BB7575251E2 Q55109311-513F9090-89A0-4A2A-BF56-9BC280891370 Q55360714-7ADE4C24-22E0-491D-A1C9-4D89D612CFDF Q58764852-BCC6F66D-C766-4F32-93D5-F813FF07AD59 Q58770132-8B463936-9F45-4667-B31E-85E34BCDF766

P2860

A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.

http://www.wikidata.org/entity/Q33916132

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@ast

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@en

type

label

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@ast

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@en

prefLabel

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@ast

A novel fluorescent probe-base ...... aining nanoparticles in serum.

@en

P1433

Q33916132-CA6260E3-B2B2-4962-8AE7-DCB941DBCF8C

P1476

Q33916132-F4409230-92CD-412E-AD49-E07028777F5D

P2093

Q33916132-2027D0B2-2836-4799-8906-9C3CBCDD9380

Q33916132-41730A8B-9C1A-45F7-9911-8D5DF2E2F8C9

Q33916132-79558776-2EA4-48C9-90BD-DD61FE42E8C3

Q33916132-966D9D43-956A-456C-93B7-7BDD141DB09D

Q33916132-FD023FC9-FE35-4115-869D-1BDA5F124B4C

P2860

Q33916132-0F6004B7-F903-4829-8BF3-4B70C78EC50F

Q33916132-10858955-65B4-4D37-A521-7887EDF2FAB5

Q33916132-1275B549-40D8-4EE3-9D41-CA30DB66D39A

Q33916132-16C7E279-FC1C-4991-9F1F-03140763D64D

Q33916132-18D1B540-323A-4128-B1F7-AB270BD81822

Q33916132-19D2DC8A-34CD-4006-9033-D9B76D29DD9F

Q33916132-19F39326-A75C-4265-AC55-E21014FCD3F1

Q33916132-1A07D5FC-14BE-47E1-BE56-9776D2BF95F0

Q33916132-1E057504-3087-495E-9AB9-E0BF5C43DC19

Q33916132-209816D6-447C-4CFE-9DF4-ECA767123DCA

P2888

Q33916132-EE7A2991-B835-40D8-AD73-3737322B3575

P304

Q33916132-C722C560-F1AA-4ADA-AA30-4CE9497BA74C

P31

Q33916132-54EBBD72-E129-4C0A-893F-B7525D61775C

P356

Q33916132-2DFD575B-8D6D-4A2B-ADE2-4E99F67526C8

P407

Q33916132-199817C4-7C42-4653-8601-4CF3DB0A159E

P433

Q33916132-0FCE1C4A-A432-4B8A-AE35-DE986F775B32

P478

Q33916132-0D5549C0-7FC2-49DC-A35C-01524F91F9B4

P50

Q33916132-013916E4-CD7C-4B38-8FD5-F144F42D82BD

Q33916132-DF510F2B-3418-4BFD-85EB-B4F63CB06AB3

P577

Q33916132-5BFD2519-2C2A-42DF-BD48-FEA18EA5DEC9

P6179

Q33916132-9A0A58EB-CB9F-4A59-9EDA-2E9B8A1AE4F2

P698

Q33916132-BC55670C-FC42-438C-B00D-9D2CD61718D1

P921

Q33916132-812D5DD4-D97E-4729-872D-A721DEA2D6C4

P932

Q33916132-00AD2E8D-D9D7-4237-B490-68AF86D7D1DD

P356

S41598-017-05474-Y

P1433

Scientific Reports

P1476

A novel fluorescent probe-base ...... taining nanoparticles in serum

@en

P2093

Andreas Pasch

http://www.w3.org/2001/XMLSchema#string

Matthias Bachtler

http://www.w3.org/2001/XMLSchema#string

Michael M X Cai

http://www.w3.org/2001/XMLSchema#string

Parisa Aghagolzadeh

http://www.w3.org/2001/XMLSchema#string

Stephen G Holt

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo near-infrared fluorescence imaging of osteoblastic activity

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology

The role of fetuin-A in mineral trafficking and deposition

Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques.

Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity

Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles

Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification

Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles

P2888

s41598-017-05474-y

P304

5686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-05474-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090696190

http://www.w3.org/2001/XMLSchema#string

P698

28720774

http://www.w3.org/2001/XMLSchema#string

P921

P932

5515983

http://www.w3.org/2001/XMLSchema#string